Active08341001Private limited companyBristol

ZIHIPP LTD

Significant control: Pfizer Inc (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Zihipp Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

ZIHIPP LTD is an active private limited company (company number 08341001) incorporated on 24 December 2012, registered in Bristol. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of £44.20m and cash of £45.22m, with 17 employees on average. Net assets rose 1251% on the prior period (£3.27m).

Peer position · net assets

By net assets it sits in the top quarter of 50 comparable companies in Bristol (median £17k, upper quartile £164k).

02

Ownership and control

1 active · 5 other
  • Pfizer Inc
    corporate entity, United States · since 13 November 2025
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Imperial Innovations Businesses Llp
    corporate entity, England · since 6 April 2016 · ceased 13 November 2018
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Professor Sir Stephen Robert Bloom
    Individual · since 6 April 2016 · ceased 13 November 2018
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • persons with significant control statement · since 13 November 2018 · ceased 28 February 2019
  • Touchstone Innovations Businesses Llp
    corporate entity, United Kingdom · since 28 February 2019 · ceased 22 September 2023
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • persons with significant control statement · since 22 September 2023 · ceased 13 November 2025

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
24 December 201213 yrs ago
Next accounts due
30 September 202623 days overdue
Confirmation statement due
7 January 2027in 76 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Small
Size band
SmallCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
£44.20m
+1251%vs Dec 2023
Cash at bank
£45.22m
+1238%vs Dec 2023
Turnover
Not reported
Employees
17
+55%vs Dec 2023
Net assets
£44.20m
Cash at bank
£45.22m
Average employees
17
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024£44.20m£45.22m—£1.40m——17
31 December 2023£3.27m£3.38m—£519k——11
Current ratio32.64Current assets ÷ creditors within one year
Cash per employee£2.66mCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £44,201,976 at 31 December 2024
  • Net assets up 10% or more on the prior period+1251.1% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 32.64
  • Cash at bank of £50,000 or moreCash £45,215,593
  • Incorporated five or more years agoIncorporated 24 December 2012
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 76 days
  2. Next accounts due23 days overdue
  3. Accounts period endNet assets £44.20m · small accounts
  4. Accounts period endNet assets £3.27m · small accounts
  5. Incorporated
08

Similar companies in Bristol

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for ZIHIPP LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.